Lexie B3 vs RCA In-Ear

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.

The RCA In-Ear is a budget-priced OTC hearing aid available for $249, earning a C grade with a SoundScore of 2.8/5 in our lab testing. This places it near the bottom of the OTC hearing aid category, ranking 64th out of 65 devices tested. In our standardized testing, the RCA In-Ear shows a mixed performance profile. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users are unlikely to experience whistling or squealing during normal wear. Own-voice comfort scores 2.6/5, which is essentially at the category average (+0.09 points), offering mixed but acceptable performance for how your own voice sounds while wearing the devices. However, the core speech performance metrics present significant limitations. Speech in quiet scores just 1.0/5, falling 1.79 points below the category average, and speech in noise also scores 1.0/5, sitting 0.48 points below average. Music streaming scored 0.0/5, indicating this device is not suitable for audio entertainment purposes. At this price point, buyers have considerably stronger options. Competitors like the Lucid Enrich Pro and JLab Hear OTC offer better sound performance at lower prices. The RCA In-Ear may appeal to those prioritizing feedback-free wear above speech clarity, but most users seeking meaningful hearing benefit should consider higher-performing alternatives in this budget segment.